Literature DB >> 649513

Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.

G Cassinelli, A Grein, P Masi, A Suarato, L Bernardi, F Arcamone, A Di Marco, A M Casazza, G Pratesi, C Soranzo.   

Abstract

A mutant strain of Streptomyces peucetius produced an anthracycline antibiotic whose structure has been established to be 4-O-demethyl-13-dihydrodaunorubicin (4), by application of spectroscopic methods and chemical degradation. A new synthesis of 4-O-demethyl-daunorubicin (carminomycin I, 2) starting from daunomycinone, together with the comparison of the antitumor activity of the anthracycline glycosides 2 and 4 are also reported.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 649513     DOI: 10.7164/antibiotics.31.178

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  Streptomycetes producing daunomycin and related compounds: do we know enough about them after 25 years?

Authors:  J Huk; M Blumauerova
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

2.  Engineered biosynthesis of aklanonic acid analogues.

Authors:  Taek Soon Lee; Chaitan Khosla; Yi Tang
Journal:  J Am Chem Soc       Date:  2005-09-07       Impact factor: 15.419

3.  Cloning and expression of daunorubicin biosynthesis genes from Streptomyces peucetius and S. peucetius subsp. caesius.

Authors:  S L Otten; K J Stutzman-Engwall; C R Hutchinson
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

4.  Expression of doxorubicin-daunorubicin resistance genes in different anthracycline-producing mutants of Streptomyces peucetius.

Authors:  A L Colombo; M M Solinas; G Perini; G Biamonti; G Zanella; M Caruso; F Torti; S Filippini; A Inventi-Solari; L Garofano
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

5.  Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study.

Authors:  C Karanes; J D Young; M K Samson; L B Smith; L A Franco; L H Baker
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

6.  Pharmacokinetics of carminomycin in dogs and humans. Preliminary report.

Authors:  S D Reich; S E Fandrich; T T Finkelstein; J E Schurig; A P Florczyk; R L Comis; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.